<DOC>
	<DOCNO>NCT02140372</DOCNO>
	<brief_summary>This pilot study . Volunteers give 1.8 mg ( 1.2 mg follow 0.6 mg one hour later ) , 1.2 mg , 0.6 mg colchicine . Blood collect prior drug administration , 2 hour colchicine administration , 24 hour colchicine administration via antecubital vein evaluate marker platelet activity inflammation .</brief_summary>
	<brief_title>Anti-platelet Effects Colchicine Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Colchicine</mesh_term>
	<criteria>Subjects must 18 year age 1 ) history cardiovascular disease , include myocardial infarction , history percutaneous coronary angioplasty stent , peripheral vascular disease stroke ; 2 ) history myelodysplasia ; 3 ) medication know affect platelet function , include nonsteroidal antiinflammatory drug , antihistamine , selective serotonin reuptake inhibitor , 5 day prior participation ; 4 ) medication know interact colchicine ; 5 ) history intolerance colchicine ; 6 ) acute chronic symptom diarrhea , nausea , vomit within 1 month prior enrollment ; 7 ) know anemia hemoglobin &lt; 10mg/dL ; 8 ) platelet count &lt; 100,000 &gt; 450,000 ; 9 ) creatinine clearance &lt; 30cc/minute ; 10 ) know hemorrhagic diathesis ; 11 ) pregnant ; 12 ) Unable consent ; 13 ) Participating compete study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>colchicine</keyword>
	<keyword>platelet activity</keyword>
	<keyword>neutrophil</keyword>
</DOC>